https://orcid.org/0000-0002-4658-7391
Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Luca Potestio, Angelo Ruggiero, Gabriella Fabbrocini, Fabrizio Martora & Matteo Megna. (2023) Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature. Psoriasis: Targets and Therapy 13, pages 19-26.
Read now
Read now
Luca Potestio, Fabrizio Martora, Gabriella Fabbrocini, Teresa Battista & Matteo Megna. (2023) Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis. Psoriasis: Targets and Therapy 13, pages 11-18.
Read now
Read now
Gemma Camiña-Conforto, Laura Mateu-Arrom, Anna López-Ferrer & Lluís Puig. (2023) Bimekizumab in the Treatment of Plaque Psoriasis: Focus on Patient Selection and Perspectives. Patient Preference and Adherence 17, pages 1541-1549.
Read now
Read now
Nanna Nyholm, Anne Danø, Henrik Schnack & Giorgio Lorenzo Colombo. (2023) The Cost-Effectiveness of Anti-IL17 Biologic Therapies for Moderate-to-Severe Plaque Psoriasis Treatment in Italy and Germany: A Sequential Treatment Analysis. ClinicoEconomics and Outcomes Research 15, pages 607-619.
Read now
Read now
Luca Potestio, Elisa Camela, Sara Cacciapuoti, Luigi Fornaro, Angelo Ruggiero, Fabrizio Martora, Teresa Battista & Matteo Megna. (2023) Biologics for the Management of Erythrodermic Psoriasis: An Updated Review. Clinical, Cosmetic and Investigational Dermatology 16, pages 2045-2059.
Read now
Read now
Matteo Megna, Elisa Camela, Angelo Ruggiero, Teresa Battista, Fabrizio Martora, Sara Cacciapuoti & Luca Potestio. (2023) Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?. Clinical, Cosmetic and Investigational Dermatology 16, pages 1677-1690.
Read now
Read now
Matteo Megna, Teresa Battista, Matteo Noto, Vincenzo Picone, Gabriella Fabbrocini, Angelo Ruggiero & Lucia Genco. (2023) Injections Site Reactions and Biologics for Psoriasis: A Questionnaire Based Real Life Study. Clinical, Cosmetic and Investigational Dermatology 16, pages 553-564.
Read now
Read now
Matilde Iorizzo & Antonella Tosti. (2023) Updates in treatment and impact of nail psoriasis. Expert Review of Clinical Immunology 19:9, pages 1091-1100.
Read now
Read now
Nanna Nyholm, Henrik Schnack, Anne Danø & François Skowron. (2023) Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany. Current Medical Research and Opinion 39:6, pages 833-842.
Read now
Read now
Angelo Ruggiero, Luca Potestio, Fabrizio Martora, Alessia Villani, Rosita Comune & Matteo Megna. (2023) Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation. Expert Opinion on Drug Safety 22:5, pages 355-362.
Read now
Read now
Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini & Luca Potestio. (2023) Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients. Expert Opinion on Drug Safety 22:1, pages 25-41.
Read now
Read now
Matteo Megna, Luca Potestio, Gabriella Fabbrocini & Angelo Ruggiero. (2022) Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study. Psoriasis: Targets and Therapy 12, pages 205-212.
Read now
Read now
Elisa Camela, Luca Potestio, Angelo Ruggiero, Sonia Sofia Ocampo-Garza, Gabriella Fabbrocini & Matteo Megna. (2022) Towards Personalized Medicine in Psoriasis: Current Progress. Psoriasis: Targets and Therapy 12, pages 231-250.
Read now
Read now
Angelo Ruggiero, Fabrizio Martora, Gabriella Fabbrocini, Alessia Villani, Claudio Marasca, Matteo Megna, Luigi Fornaro, Rosita Comune & Luca Potestio. (2022) The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review. Clinical, Cosmetic and Investigational Dermatology 15, pages 2785-2793.
Read now
Read now
Elia Rosi, Maria Thais Fastame, Antonella Di Cesare & Francesca Prignano. (2022) Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review. Expert Opinion on Biological Therapy 22:12, pages 1475-1487.
Read now
Read now
Articles from other publishers (3)
Sonali Batta, Ramlah Khan, Marcus Zaayman, Allison Limmer, Dario Kivelevitch & Alan Menter. (2023) IL-17 and -23 Inhibitors for the Treatment of Psoriasis. EMJ Allergy & Immunology.
Crossref
Crossref
Jan Krejsek. (2023) Immunopathological inflammation in patients with psoriasis is effectively reduced by bimekizumab treatment targeting simultaneously IL-17A and IL-17F. Dermatologie pro praxi 17:1, pages 16-19.
Crossref
Crossref
Jan Šternberský & Martin Tichý. (2022) Bimekizumab - new biological drug in the treatment of psoriasis. Dermatologie pro praxi 16:4, pages 231-234.
Crossref
Crossref